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In cells, protein-protein interaction domains control the
organization of multiprotein complexes in signal trans-
duction networks, thereby determining the responses of cells
to many different stimuli [1]. Such domains are generally
defined as independently folded structural modules that can
bind a protein ligand or a peptide motif. There are at least 81
defined protein-interaction domains in eukaryotic cells that
control the organization and responses of signaling networks
[2]. Even a given domain can have significant complexity
and be used repeatedly in different contexts. For example,
more than 120 Src-homology 2 (SH2) domains - which
recognize phospho-tyrosines - are encoded in the human
genome. Each SH2 domain has amino acid variations that
alter the sequence context within which it recognizes a
phospho-tyrosine residue. In higher eukaryotes especially, a
single protein is typically composed of multiple domains,
and so the ability to reconfigure the repertoire of domain
composition and position within a protein provides a
powerful mechanism for reconfiguring the architecture of
signaling networks both in evolution and by design engi-
neering [3-5].
Although domain-wiring models, defined by domain-depen-
dent protein metrications, have proved to be particularly
valuable in predicting protein interactions within complex
networks, they best describe how the primary backbone of
the network is laid out. The high-fidelity choice of
interaction partner can only be partly explained by domain-
wiring. For instance, a degree of interaction specificity can
be controlled by variation within the domain itself, as
evidenced by the 120 or so different members of the SH2-
domain family. However, it is clear that in many cases the
specificity of a protein interaction cannot lie entirely with
the interacting amino acids in the binding site, and a degree
of ‘fine-tuning’ of specificity occurs elsewhere in the protein.
The recent work of Mody et al. [6] published in Nature Cell
Biology helps shed light on how the modularity of two yeast
mitogen-activated protein kinases (MAPKs) establishes a
capability for altering the specificity of interaction and,
therefore, for changing the topology of a signaling network.
T Th he e   m mo od du ul la ar r   n na at tu ur re e   o of f   M MA AP PK Ks s
MAPKs are relatively small proteins with an average mass of
around 40 kDa. The three-dimensional structures of several
MAPKs are known and show them to be compact globular
proteins [7,8]. MAPKs are serine-threonine kinases that
phosphorylate diverse transcription factors, intracellular
enzymes and cytoskeletal proteins to control gene expres-
sion and the physiological program of the cell. They are
activated by MAPK kinases (MKKs) via the phosphorylation
of a threonine and a tyrosine in a conserved Thr-X-Tyr motif
on the ‘phosphorylation lip’ of the kinase domain, and are
inactivated by specific phosphatases that remove these
phosphate groups. In addition, MAPKs often bind specific
scaffold proteins such as Ste5 in yeast and KSR in mamma-
lian cells [9,10]. In response to a particular signal (such as
pheromone signaling), scaffold proteins such as Ste5 bindand organize specific components of a ‘MAPK cascade’ -
MAPK kinase kinases (MKKKs), MKKs and MAPKs - in
such a way that they interact effectively with each other
[9,10]. Each different MAPK must therefore interact with
high specificity with multiple proteins so that MAPK
signaling networks responding to different stimuli can be
formed and regulated.
The specific interactions MAPKs make with their cognate
MKKs, substrates, scaffolds and phosphatases contribute
significantly to pathway specificity, and involve a docking
groove found in all MAPKs that contains a basic region and a
hydrophobic region and binds the hydrophobic docking-
peptide motif φA-X-φB (where  φA and  φB are hydrophobic
residues - Leu, Ile or Val) [11-13]. However, given the relative
conservation of docking-groove amino acid sequence among
MAPKs, it is unlikely that the docking groove and the
cognate binding motifs are the only mechanism for
controlling the specific interaction of MAPKs with their
many ligands.
The recent work of Mody et al. [6] provides a significant
advance beyond the docking groove in our understanding of
MAPK modularity and the determinants of its interaction
with other proteins. These investigators examined the
sequence alignments of multiple yeast, human and plant
orthologs of Saccharomyces cerevisiae MAPKs. Focusing on
Fus3 and Hog1, S. cerevisiae orthologs of the mammalian
MAPKs ERK1/2 and p38, respectively, they hypothesized
that variable residues in particular surface regions or
‘patches’ in the two proteins could contribute to the different
activation and substrate specificities of Fus3 and Hog1. Fus3
is activated by the MKK Ste7 and phosphorylates substrates
such as the cell-cycle arrest mediator Far1 in response to
mating pheromone. In contrast, Hog1 is activated by the
MKK Pbs2 in response to hyperosmolar shock and phos-
phorylates several transcription factors, including Hot1 and
Sko1, thus initiating a response to osmolyte imbalance.
Mody  et al. investigated the significance of the sequence
patch in controlling the specificities of Fus3 and Hog1 for
their upstream MKKs and downstream transcription-factor
substrates by constructing kinases containing different
combinations of amino acids from the Fus3 and Hog1
patches (Figure 1). The chimeric proteins were expressed in
appropriate genetic backgrounds in S. cerevisiae and tested
for their ability to signal pheromone- or hyperosmolar-
stimulated responses.
Mody et al. [6] used six different segments of Fus3 and Hog1
in the combinations shown in Figure 1. The segments ‘B’ (or
‘b’) and ‘F’ (or ‘f’) contain the docking-groove sequences. The
BF segments from Fus3 were effective in maintaining the
mating-pheromone response mediated by the upstream
MKK Ste7, and the bf segments from Hog1 were similarly
effective in maintaining the sorbitol hyperosmolar response
(Figure 1a and 1b, respectively). These effects were most
clear-cut when the chimeric MAPKs were expressed from
low-copy-number plasmids, which is more representative of
their physiological levels. When high-copy plasmids for high
protein expression were used, there is significant crossover,
and responses to both pheromone and sorbitol were seen
with each MAPK. This is due to the high protein expression
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F Fi ig gu ur re e   1 1
The responses to pheromone and sorbitol in the presence of different
Fus3 and Hog1 hybrid proteins. ( (a a) ) The hybrids of Fus3 and Hog1 are
shown on the left. Capital letters ABCDEF (black) each represent a
segment of Fus3, while the lower-case letters abcdef (red) each represent
a segment of Hog1. The relative responses to pheromone and sorbitol
were measured using a FUS1 promoter-driven reporter gene to detect
Fus3 activity (horizontal blue bars). Plasmids bearing the hybrid genes
were introduced into cells deleted for endogenous Fus3 (fus3∆) and the
MAPK Kss1 (kss1∆), an alternative target for Ste5 activation. Mating
activity is scored from +++ to - (none). The lower panel in (a) shows the
crossover response in which sorbitol activates the FUS1-driven reporter
gene when there is high-copy expression of the ABcdEF hybrid. The ∆
symbol indicates that the response was maintained in a Ste7-deleted
background. ( (b b) ) The relative responses to pheromone and sorbitol were
measured using a STL1 promoter-driven reporter gene to detect Hog1
activity (represented by blue bars). Relative efficiency of growth on
sorbitol is scored from +++ to -. Data in (a) and (b) are from [6].
( (c c) ) Model modified from [6] depicting the ability of different sequence
patches in Fus3/Hog1 hybrids to regulate the pheromone and osmolyte
activation of hybrid MAPKs.
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Notably, cells expressing ABcdEF or ABcdeF had constitu-
tive Fus3 activity. This is particularly interesting because
replacing Thr and Tyr in the Thr-X-Tyr activation-loop motif
with phosphomimetics does not activate Fus3 or Hog1.
These results suggest that the CD segments have a role in
controlling the inactive state of Fus3 and that substitution
with the cd region of Hog1 relieves this inhibition. The three
hybrids ABcdEF, ABcdeF and aBcdeF showed Fus3 activity
in response to sorbitol, even when Ste7 (the Fus3 MKK) and
Hog1 were deleted. That result indicated a direct activation
of the chimeric protein by Pbs2, the MKK for Hog1, which
was now able to recognize Fus3. This is particularly telling,
because these three hybrids encode the docking-groove BF
segments of Fus3, and it implies that segments A/a, C/c, D/d
and E/e in Fus3 and Hog1 make significant contributions to
recognition by their cognate MKKs.
Figure 1c summarizes some of the salient findings from the
hybrid analysis. These indicate that an aBCDEF hybrid
produces only a low-level mating response, thus implicating
segment A in the interaction of Fus3 with Far1. This is not
too surprising, as segment A/a includes the ATP-binding
pocket and includes residues involved in substrate
recognition. Segment ‘d’ is important for transducing a
hyperosmolar response to either pheromone or sorbitol. It is
required, although not sufficient, for activation of hybrid
MAPKs by sorbitol at low-copy expression. Segment d has a
significant deletion relative to D, with a somewhat neutral
drift in the amino acid differences in D, suggesting that the
insert might be significant for the selectivity of Fus3 for Ste7
and Far1 in the mating response. Overall, the hybrid analysis
shows that the different sequence patches in A/a, C/c, D/d
and E/e play significant roles in specificity in addition to the
roles played by the docking groove and activation loop
(comprising segments B/b and F/f).
E En ng gi in ne ee er ri in ng g   M MA AP PK K   s si ig gn na al li in ng g   d dy yn na am mi ic cs s
Switching or modification of specific sequences on the MAPK
surface enables the generation of promiscuous enzymes that
respond to multiple activators and act on multiple substrates,
the evolution of new specificities within signaling networks,
and the engineering of MAPK interactions to rewire network
behavior. The identification by Mody et al. [6] of regions
outside the docking groove that support interaction specificity
expands the ability to engineer MAPKs to have new functions.
Thus, engineering these sequence patches as well as the
docking groove will enable the development of MAPKs with
unique connections for upstream activators, downstream
substrates, inactivating phosphatases and the scaffolds that
organize the MAPK signaling complexes. Such specificity modi-
fications could be engineered in combination with scaffold
modifications to allow assembly of MAPK cascades that
modulate positive- and negative-feedback loops controlling
duration and magnitude of activation, sensitivity of the system
to specific stimuli, and the ability to tune the system [14,15].
The modular nature of MAPKs and their scaffolds allows
rational design principles to be used to build synthetic
responses for therapeutic uses. For example, one can imagine
a surface receptor expressed in vascular sentinel cells that
binds a specific disease-related biomarker released into the
bloodstream that, in turn, activates a synthetic MAPK system
and sounds the alarm for early diagnosis and therapeutic
intervention. The extensive and growing knowledge base for
designing synthetic MAPKs and scaffolds suggests that such
ideas are probably already in the making.
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